Sentence examples for described dual from inspiring English sources

Certainly both drugs have dose-dependent effects; however, previously described "dual mechanisms" of these drugs should not be interpreted as shared.

In summary, the single vector based strategy demonstrated here for the expression of N-myristoylated HIV-1 Nef in E. coli offers a simple, general, easy to use, straightforward and efficient alternative to the previously described dual plasmid systems.

A recent report by Abu-Raddad and colleagues described dual HIV/Plasmodium infection in Kisumu, Kenya (pop 200,000) enhanced the spread of both pathogens, leading to an increase of, from 1980 to 2005, approximately one million episodes of clinical malaria and 8,500 cases of HIV infection [10].

For example, no respondents described dual practice being addressed directly during regular staff meetings.

The described dual indexing approach [ 16] can also be applied to other genetic markers, provided some considerations are taken into account as described for ITS2 in this study.

Qualitatively, the cofactor recruitment signature of aleglitazar on PPARγ was roughly in line with that of the other full PPARγ agonists (rosiglitazone and pioglitazone) and previously described dual PPARα/γ agonists (muraglitazar and tesaglitazar).

The ability to invent non-promiscuous, high affinity antibodies which are 'specific' for more than one antigen such as the recently described dual-specific Two-in-One DAF antibodies, provides not only insights into the evolution of antibody specificity but also a promise of powerful medicines fully within the paradigm of targeted therapies.

To describe dual eligibles' claims before and after Medicare Part D and to evaluate the effect that Medicare Part D has had on the claim percent gross margin (CPGM) earned by Texas community independent pharmacies.

Previously it has been shown that the single-action transferases can be used as a model to describe dual transferase PmHS2 activity (Chavaroche et al. 2011); thus, immobilized PmHS2 single-action transferases can also be used to study PmHS2 polymerization mechanism.

In this work, we describe dual-modality nanoparticle drug conjugates (NDCs) which utilize protease sensitive linkers to attached drug compounds and imaging labels to a clinically translated class of ultrasmall silica nanoparticle (C′ dots).

Herein we describe dual-modal MR/fluorescent contrast agents that show specific binding to ZnII as tools to image β-cell mass and function in diabetes.